Ha Noi - Hai Duong Beer JSC (HNX:HAD)

Intra-Cellular Therapies Cash Flow Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	6,946	6,308	6,006	10,531	3,151	8,278
Depreciation & Amortization	4,861	5,262	5,424	5,972	7,748	8,289
Loss (Gain) From Sale of Assets	-	-	-	-2,917	-	-22.73
Other Operating Activities	-2,316	-1,424	-3,669	-3,229	-5,102	-6,568
Change in Accounts Receivable	-1,609	-5.56	-448.71	-62.84	141.76	1,457
Change in Inventory	2,395	-942.39	-1,415	3,102	-5,693	5,975
Change in Accounts Payable	-1,600	1,404	-906.74	1,361	782.09	1,879
Change in Income Taxes	-1,561	-1,561	-392.78	-	-	-
Change in Other Net Operating Assets	-4,071	-258.68	-2,408	-1,157	-707.11	740.18
Operating Cash Flow	3,044	8,782	2,189	13,600	321.09	20,028
Operating Cash Flow Growth	-69.63%	301.20%	-83.91%	4135.56%	-98.40%	400.89%
Capital Expenditures	-2,995	-2,393	-4,006	-2,465	-1,476	-2,795
Sale of Property, Plant & Equipment	-	-	-	40.91	-	22.73
Investment in Securities	-7,000	-7,000	3,000	-	-	-
Other Investing Activities	3,943	3,149	5,164	2,152	2,038	2,415
Investing Cash Flow	2,947	-6,244	4,158	-11,272	1,562	-8,357
Common Dividends Paid	-4,794	-4,794	-4,794	-3,998	-3,995	-14,199
Financing Cash Flow	-4,794	-4,794	-4,794	-3,998	-3,995	-14,199
Net Cash Flow	1,196	-2,257	1,553	-1,670	-2,113	-2,529
Free Cash Flow	48.27	6,388	-1,817	11,134	-1,155	17,233
Free Cash Flow Growth	-99.36%	-	-	-	-	-
Free Cash Flow Margin	0.03%	3.72%	-1.09%	7.34%	-0.91%	11.46%
Free Cash Flow Per Share	12.07	1597.10	-454.30	-	-	-
Cash Income Tax Paid	75.45	-	-	2,843	343.34	2,770
Levered Free Cash Flow	4,604	6,867	2,141	12,471	3,733	-
Unlevered Free Cash Flow	4,604	6,867	2,141	12,471	3,733	-
Change in Net Working Capital	533.14	-963.26	682.61	-2,600	3,651	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.